Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Arena Pharmaceuticals Company Profile (NASDAQ:ARNA)

Consensus Ratings for Arena Pharmaceuticals (NASDAQ:ARNA) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $8.00 (90.93% upside)

Analysts' Ratings History for Arena Pharmaceuticals (NASDAQ:ARNA)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/30/2014BMO Capital MarketsReiterated RatingMarket PerformViewTweet This Rating  Share This Rating on StockTwits
9/4/2014Credit SuisseInitiated CoverageUnderperformViewTweet This Rating  Share This Rating on StockTwits
8/7/2014WallachBeth CapitalLower Price TargetBuy$9.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
4/24/2014Wells Fargo & Co.Initiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
11/15/2013WallachBeth CapitalInitiated CoverageBuy$9.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2013Leerink SwannReiterated RatingOutperform$12.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2013Jefferies GroupReiterated RatingBuy$12.00ViewTweet This Rating  Share This Rating on StockTwits
10/16/2013Needham & Company LLCReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
10/3/2013Cowen and CompanyInitiated CoverageMarket Perform$4.50ViewTweet This Rating  Share This Rating on StockTwits
9/30/2013Credit SuisseLower Price TargetUnderperform$5.00 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
8/1/2013Piper JaffrayLower Price TargetOverweight$11.50ViewTweet This Rating  Share This Rating on StockTwits
6/19/2013Leerink SwannReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
6/11/2013Piper JaffrayReiterated RatingOverweight$9.00 -> $12.50ViewTweet This Rating  Share This Rating on StockTwits
5/6/2013Credit SuisseLower Price Target$6.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2013JPMorgan Chase & Co.Lower Price Target$7.00ViewTweet This Rating  Share This Rating on StockTwits
2/6/2013Leerink SwannInitiated CoverageOutperform$11.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2013TheStreetReiterated RatingSellViewTweet This Rating  Share This Rating on StockTwits
12/27/2012TheStreetReiterated RatingSellViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/28/2012 forward)